Literature DB >> 17910640

Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.

Catherine J Wu, Mark Gladwin, John Tisdale, Matthew Hsieh, Terence Law, Melinda Biernacki, Shelby Rogers, Xunde Wang, Mark Walters, David Zahrieh, Joseph H Antin, Jerome Ritz, Lakshamanan Krishnamurti.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17910640      PMCID： PMC2742964          DOI： 10.1111/j.1365-2141.2007.06803.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Red cell exchange in sickle cell disease.

Authors:  Paul S Swerdlow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

2.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

3.  Circulating activated endothelial cells in sickle cell anemia.

Authors:  A Solovey; Y Lin; P Browne; S Choong; E Wayner; R P Hebbel
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

4.  Evidence for ineffective erythropoiesis in severe sickle cell disease.

Authors:  Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

5.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

Review 6.  Reduced-intensity regimens in allogeneic hematopoietic stem cell transplantation for hemoglobinopathies.

Authors:  Franco Locatelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

7.  Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease.

Authors:  Leslie S Kean; Elizabeth A Manci; Jennifer Perry; Can Balkan; Shana Coley; David Holtzclaw; Andrew B Adams; Christian P Larsen; Lewis L Hsu; David R Archer
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

8.  Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival.

Authors:  Oswaldo Castro; Mohammed Hoque; Bernice D Brown
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113
  8 in total
  24 in total

Review 1.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.

Authors:  Rudolph Kirk R Schultz; Kevin Scott Baker; Jaap J Boelens; Catherine M Bollard; R Maarten Egeler; Mort Cowan; Ruth Ladenstein; Arjan Lankester; Franco Locatelli; Anita Lawitschka; John E Levine; Mignon Loh; Eneida Nemecek; Charlotte Niemeyer; Vinod K Prasad; Vanderson Rocha; Shalini Shenoy; Brigitte Strahm; Paul Veys; Donna Wall; Peter Bader; Stephan A Grupp; Michael A Pulsipher; Christina Peters
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-21       Impact factor: 5.742

3.  Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.

Authors:  Mark A DeWitt; Wendy Magis; Nicolas L Bray; Tianjiao Wang; Jennifer R Berman; Fabrizia Urbinati; Seok-Jin Heo; Therese Mitros; Denise P Muñoz; Dario Boffelli; Donald B Kohn; Mark C Walters; Dana Carroll; David I K Martin; Jacob E Corn
Journal:  Sci Transl Med       Date:  2016-10-12       Impact factor: 17.956

4.  Gene Therapy for Hemoglobinopathies: Tremendous Successes and Remaining Caveats.

Authors:  Punam Malik
Journal:  Mol Ther       Date:  2016-04       Impact factor: 11.454

Review 5.  How I treat sickle cell disease with hematopoietic cell transplantation.

Authors:  Elizabeth O Stenger; Shalini Shenoy; Lakshmanan Krishnamurti
Journal:  Blood       Date:  2019-12-19       Impact factor: 22.113

6.  Normalization of red cell enolase level following allogeneic bone marrow transplantation in a child with Diamond-Blackfan anemia.

Authors:  Jeong A Park; Yeon Jung Lim; Hyeon Jin Park; Sun Young Kong; Byung Kiu Park; Thad T Ghim
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

7.  Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.

Authors:  Lakshmanan Krishnamurti; Donna S Neuberg; Keith M Sullivan; Naynesh R Kamani; Allistair Abraham; Federico Campigotto; Wandi Zhang; Thabat Dahdoul; Laura De Castro; Suhag Parikh; Nitya Bakshi; Ann Haight; Kathryn L Hassell; Rebekah Loving; Joseph Rosenthal; Shannon L Smith; Wally Smith; Marcus Spearman; Kristen Stevenson; Catherine J Wu; Christina Wiedl; Edmund K Waller; Mark C Walters
Journal:  Am J Hematol       Date:  2019-02-11       Impact factor: 10.047

Review 8.  Update of hematopoietic cell transplantation for sickle cell disease.

Authors:  Mark C Walters
Journal:  Curr Opin Hematol       Date:  2015-05       Impact factor: 3.284

Review 9.  Blood and marrow transplantation for sickle cell disease: overcoming barriers to success.

Authors:  Javier Bolaños-Meade; Robert A Brodsky
Journal:  Curr Opin Oncol       Date:  2009-03       Impact factor: 3.645

10.  β-globin gene transfer to human bone marrow for sickle cell disease.

Authors:  Zulema Romero; Fabrizia Urbinati; Sabine Geiger; Aaron R Cooper; Jennifer Wherley; Michael L Kaufman; Roger P Hollis; Rafael Ruiz de Assin; Shantha Senadheera; Arineh Sahagian; Xiangyang Jin; Alyse Gellis; Xiaoyan Wang; David Gjertson; Satiro Deoliveira; Pamela Kempert; Sally Shupien; Hisham Abdel-Azim; Mark C Walters; Herbert J Meiselman; Rosalinda B Wenby; Theresa Gruber; Victor Marder; Thomas D Coates; Donald B Kohn
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.